SS-31 was also shown to protect against diabetic kidney disease via maintaining physiologic superoxide levels [102], preventing tubulointerstitial injury by decreasing DRP1 expression and inhibiting mitochondrial fission [103], preventing cellular apoptosis [104] and ROS generation [105]. Here, DNM1L is linked to diabetic kidney disease.